| Business: |
(Incorporated in Delaware)
Note: This is NOT an IPO. This is an uplisting to the NYSE-AmEx – also known as the NYSE-American Exchange – from the OTCID Market (“OTCID”) where the company’s stock is listed under the ticker symbol “VRHI.” As of Oct. 1, 2025, the last reported price of Veri MedTech Holdings’ stock was $1.50 per share at market close.
We conduct our business through our wholly owned subsidiaries. Our subsidiary, Veriheal, Inc. (“Veriheal”) was founded in the state of Delaware on November 17, 2017, by Joshua Green and Samuel Adetunji to provide concierge services to patients seeking prescription cards for medical marijuana.
Veri Medtech Holdings serves as a holding company for operating wholly owned subsidiaries:
|
|
|
·
|
Veriheal Inc. was formed in the state of Delaware on November 17, 2017
|
|
|
·
|
DosePop Inc. (f/k/a “Verinew”) was formed in the state of Delaware on June 23, 2023
|
|
|
·
|
Alternative Medical Clinic LLC was formed in the state of Delaware on April 28, 2023
|
Via our wholly owned subsidiary, Veriheal, we offer medical marijuana patients a user-friendly experience on our company developed healthcare technology platform to speak with doctors directly. Patients can locate a physician on our platform and use the scheduling tool to set an appointment. Once we receive the approval or prescription from the patient’s physician, we then complete the required paperwork for submission to the relevant state for the medical marijuana recommendation.
|
Our websites are located at www.veriheal.com,www.Dosepop.com and VeriMedtech.com. Information on our website is not part of this prospectus or the offering.
Our principal executive offices are located at 1660 International Dr., Suite 600, McLean, VA 22102, and our telephone number is 1-202-410–7411.
We also operate at the following location:
|
|
|
|
|
|
|
|
|
·
|
1700 East 17th Avenue, Denver, CO, 80218
|
|
|
|
|
|
We recently introduced a personalized consultation service on our platform that provides 15 and 25 minute one-on-one online sessions with patients and physicians or certified experts. These consults meet the desires of patients seeking information and more education about how they can best incorporate medical cannabis in their lives to an optimal benefit. The consultations are often centered around terpene and cannabinoid products. Additionally, like a nutritionist or a dietician, the Company’s coaches provide a personalized action plan for patients and answer any queries. The consultations are priced according to the time spent with the specialist and can be booked at any point in time as they are not tied to any medical cannabis certification.
Revenue
We generate revenue from our medical marijuana card services and charge a fee ranging from approximately $100 to $200 for each card and annual renewals. We have generated revenue of approximately $17 million and $22 million from our medical marijuana cards services during the years ended December 31, 2024, and 2023, respectively.
|
Note: See the note about “Going Concern” risk in the prospectus.
Note: Net loss and revenue are for the 12 months that ended Dec. 31, 2024.
(Note: Veri MedTech Holdings filed its S-1 on Nov. 14, 2025, for the uplisting of its common stock to the NYSE-American Exchange from the OTCID Market.)
|
